Key result
Temporary verapamil yields complete resolution of swallowing-induced atrial tachycardia in hypertrophic cardiomyopathy.
Why the study?
Swallowing-induced atrial tachycardia is a rare arrhythmia usually requiring radiofrequency catheter ablation, with limited data on its occurrence in genotyped hypertrophic cardiomyopathy patients.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May support verapamil trial before ablation in swallowing-induced atrial tachycardia with hypertrophic cardiomyopathy; hypothesis-generating from single case.
Most cases of swallowing-induced atrial tachycardia require radiofrequency catheter ablation for a permanent cure; however, the arrhythmia subsided after temporary prescription of verapamil in a patient with genotyped hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Fujino et al. (2020) conducted a case report in Swallowing-induced atrial tachycardia and hypertrophic cardiomyopathy (n=1). Verapamil was evaluated on Resolution of swallowing-induced atrial tachycardia. Temporary prescription of verapamil led to complete and long-term resolution of swallowing-induced atrial tachycardia in a patient with genotyped hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: